Search results
Wisconsin high school football coach unable to get chemo due to shortage dies at 60
NBC News via Yahoo News· 21 hours agoIn April 2024, the U.S. Food and Drug Administration website indicates that 15 oncology agents are...
Stock market today: gloomy start to May ahead of Fed decision
Newsweek· 2 hours agoU.S. futures were down Wednesday morning ahead of a decision by the Federal Reserve on interest...
Pfizer and Genmab’s Tivdak wins full FDA approval for cervical cancer
Pharmaceutical Technology via Yahoo Finance· 23 hours agoGlobalData is the parent company of Pharmaceutical Technology. Pfizer is also seeking European...
Farm package designed to boost Georgia’s top industry of agriculture signed into law
Columbus Ledger-Enquirer via Yahoo News· 4 hours agoThe legislation also applies to any type of land located within 10 miles of a military installation....
The Best Canned Beef Stew Is Not From A Powerhouse Brand
Mashed via Yahoo News· 22 hours agoYes, as in the survival food kit and camping supply brand. The stew does have a 4.7-star rating on...
Is Pfizer Stock A Sell As Shares Hit An 11-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 7 days agoThe company also recently said its new drug Adcetris — courtesy of its $43 billion takeover of...
These Are the Drugs America Is Running Short On
247wallst.com· 2 days agoDrug shortages in America are the result of supply line challenges, profit-based operations, and company closures.
How Crackers Went From Survival Food to Gourmet Treat
The Wall Street Journal· 5 days agoInvented to feed soldiers and sailors on the move, crackers are now showing up on high-end...
The family who turned Asheville into Beer City celebrates 30 years of business
Asheville Citizen-Times via Yahoo Finance· 4 hours agoAshburn said the company has remained family-owned and operated and employs a local workforce...
G1 Therapeutics Provides First Quarter 2024 Financial Results and Operational Highlights - G1...
Benzinga· 2 hours ago- Achieved $14.1 Million in Net Revenue from Sales of COSELA® (trilaciclib) for First Quarter 2024 - - Reaffirmed 2024 Net COSELA Revenue Guidance of $60 to $70 Million - - Announced That Updated Efficacy Results